SAVANNAH Phase II trial demonstrated high and durable response rates with savolitinib plus TAGRISSO® in MET-high lung cancer, representing a ...
The investment objective of the Fund is to replicate the performance of the FTSE UK ESG Low Carbon Emissions Select Index (the “Index”), while minimising as far ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback